| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 10 4684-4693, Copyright © 1994 by American Association of Immunologists
ARTICLES |
PY Perera, SA Barber, LM Ching and SN Vogel
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814.
The synthetic flavone analogue 5,6-dimethylxanthenone-4-acetic acid (5,6-MeXAA) has shown promise as an antitumor agent and is currently a candidate for clinical trials. Because 5,6-MeXAA has been shown in a murine macrophage and a human myelomonocytic cell line to induce TNF- alpha mRNA and to activate macrophages to become tumoricidal, actions that are shared with bacterial LPS, we sought to determine the level of LPS mimetic activity exhibited by this low m.w. macrophage-activating agent. To elucidate its mechanisms of action, the capacity to induce a panel of LPS-inducible genes was assessed. 5,6-MeXAA was found to induce a subset of LPS-inducible genes within the panel in both Lpsn and Lpsd primary murine macrophages. Of the six LPS-inducible genes examined, there was marked induction of IP-10, D8, and D3; low induction of TNF-alpha gene expression; and insignificant induction of TNFR-2 and IL-1 beta genes. 5,6-MeXAA was also found to be a potent inducer of IFNs in macrophages of both strains, and of increased expression of the genes that encode the IFN regulatory factors IRF-1, IRF-2, and ICSBP. In contrast with LPS, 5,6-MeXAA failed to induce significantly any of the 40- to 45-kDa tyrosine phosphoproteins induced by LPS. These data suggest that 5,6-MeXAA shares with LPS certain biochemical pathways that lead to gene induction and allow for the additional dissection of the relationship of tyrosine phosphorylation and the expression of specific genes.
This article has been cited by other articles:
|
|
 |
|
  D.-F. Lee and M.-C. Hung Advances in Targeting IKK and IKK-Related Kinases for Cancer Therapy Clin. Cancer Res., September 15, 2008; 14(18): 5656 - 5662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. J. Roberts, N. Goutagny, P.-Y. Perera, H. Kato, H. Kumar, T. Kawai, S. Akira, R. Savan, D. van Echo, K. A. Fitzgerald, et al. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis J. Exp. Med., July 9, 2007; 204(7): 1559 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cao, B. C Baguley, and L.-M. Ching Interferon-inducible Protein 10 Induction and Inhibition of Angiogenesis in Vivo by the Antitumor Agent 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Cancer Res., February 1, 2001; 61(4): 1517 - 1521. [Abstract] [Full Text]
|
|
|
|
 |
|
 P.-Y. Perera, T. N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert, and S. N. Vogel CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression J. Immunol., January 1, 2001; 166(1): 574 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-M. Ching, D. Goldsmith, W. R. Joseph, H. Korner, J. D. Sedgwick, and B. C. Baguley Induction of Intratumoral Tumor Necrosis Factor (TNF) Synthesis and Hemorrhagic Necrosis by 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA) in TNF Knockout Mice Cancer Res., July 1, 1999; 59(14): 3304 - 3307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zaks-Zilberman, C. A. Salkowski, T. Elsasser, F. Cuttitta, and S. N. Vogel Induction of Adrenomedullin mRNA and Protein by Lipopolysaccharide and Paclitaxel (Taxol) in Murine Macrophages Infect. Immun., October 1, 1998; 66(10): 4669 - 4675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.A. Barber, C.A. Salkowski, M.J. Fultz, P-Y. Perera, R. McNally, and S.N. Vogel Regulation of gene expression and nitric oxide production in murine macrophages by the serine/threonine phosphatase inhibitor okadaic acid Innate Immunity, February 1, 1996; 3(1): 19 - 27. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
